Home
/
Bausch Health Companies Inc.
/
Financials
/
Quarterly
Bausch Health Companies Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bausch Health Companies Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$2.00B
May 8, 2018
Q3
2017
Sep 30, 2017
$2.22B
Nov 7, 2017
Q2
2017
Jun 30, 2017
$2.23B
Aug 8, 2017
Q1
2018
Mar 31, 2017
$2.11B
May 8, 2018
Q3
2017
Sep 30, 2016
$2.48B
Nov 7, 2017
Q2
2017
Jun 30, 2016
$2.42B
Aug 8, 2017
Q1
2017
Mar 31, 2016
$2.37B
May 9, 2017
Q3
2016
Sep 30, 2015
$2.79B
Nov 9, 2016
Q2
2016
Jun 30, 2015
$2.73B
Aug 9, 2016
Q1
2016
Mar 31, 2015
$2.17B
Jun 7, 2016
Q3
2015
Sep 30, 2014
$2.06B
Oct 26, 2015
Q2
2015
Jun 30, 2014
$2.04B
Jul 28, 2015
Q1
2015
Mar 31, 2014
$1.89B
Apr 30, 2015
Q3
2014
Sep 30, 2013
$1.54B
Oct 24, 2014
Q2
2014
Jun 30, 2013
$1.10B
Aug 1, 2014
Q1
2014
Mar 31, 2013
$1.07B
May 9, 2014
Q3
2013
Sep 30, 2012
$884.14M
Nov 1, 2013
Q2
2013
Jun 30, 2012
$820.09M
Aug 7, 2013
Q1
2013
Mar 31, 2012
$856.10M
May 3, 2013
Q3
2012
Sep 30, 2011
$600.58M
Nov 5, 2012
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.68B
Oct 30, 2025
Q2
2025
Jun 30, 2025
$2.53B
Jul 31, 2025
Q1
2025
Mar 31, 2025
$2.26B
May 1, 2025
Q3
2025
Sep 30, 2024
$2.51B
Oct 30, 2025
Q2
2025
Jun 30, 2024
$2.40B
Jul 31, 2025
Q1
2025
Mar 31, 2024
$2.15B
May 1, 2025
Q3
2024
Sep 30, 2023
$2.24B
Oct 31, 2024
Q2
2024
Jun 30, 2023
$2.17B
Aug 1, 2024
Q1
2024
Mar 31, 2023
$1.94B
May 2, 2024
Q3
2023
Sep 30, 2022
$2.05B
Nov 2, 2023
Q2
2023
Jun 30, 2022
$1.97B
Aug 3, 2023
Q1
2023
Mar 31, 2022
$1.92B
May 4, 2023
Q3
2022
Sep 30, 2021
$2.11B
Nov 3, 2022
Q2
2022
Jun 30, 2021
$2.10B
Aug 9, 2022
Q1
2022
Mar 31, 2021
$2.03B
May 10, 2022
Q3
2021
Sep 30, 2020
$2.14B
Nov 2, 2021
Q2
2021
Jun 30, 2020
$1.66B
Aug 3, 2021
Q1
2021
Mar 31, 2020
$2.01B
May 4, 2021
Q3
2020
Sep 30, 2019
$2.21B
Nov 3, 2020
Q2
2020
Jun 30, 2019
$2.15B
Aug 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$179.00M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$148.00M
Jul 31, 2025
Q1
2025
Mar 31, 2025
($58.00M)
May 1, 2025
Q3
2025
Sep 30, 2024
($85.00M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
$10.00M
Jul 31, 2025
Q1
2025
Mar 31, 2024
($64.00M)
May 1, 2025
Q3
2024
Sep 30, 2023
($378.00M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
$26.00M
Aug 1, 2024
Q1
2024
Mar 31, 2023
($201.00M)
May 2, 2024
Q3
2023
Sep 30, 2022
$399.00M
Nov 2, 2023
Q2
2023
Jun 30, 2022
($145.00M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($69.00M)
May 4, 2023
Q3
2022
Sep 30, 2021
$188.00M
Nov 3, 2022
Q2
2022
Jun 30, 2021
($595.00M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($610.00M)
May 10, 2022
Q3
2021
Sep 30, 2020
$71.00M
Nov 2, 2021
Q2
2021
Jun 30, 2020
($326.00M)
Aug 3, 2021
Q1
2021
Mar 31, 2020
($152.00M)
May 4, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$619.00M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$444.00M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$276.00M
May 1, 2025
Q3
2025
Sep 30, 2024
$318.00M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$389.00M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$281.00M
May 1, 2025
Q3
2024
Sep 30, 2023
$14.00M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$412.00M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$175.00M
May 2, 2024
Q3
2023
Sep 30, 2022
$244.00M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$161.00M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$285.00M
May 4, 2023
Q3
2022
Sep 30, 2021
$574.00M
Nov 3, 2022
Q2
2022
Jun 30, 2021
($270.00M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($221.00M)
May 10, 2022
Q3
2021
Sep 30, 2020
$460.00M
Nov 2, 2021
Q2
2021
Jun 30, 2020
($27.00M)
Aug 3, 2021
Q1
2021
Mar 31, 2020
$248.00M
May 4, 2021
Q3
2020
Sep 30, 2019
$329.00M
Nov 3, 2020
Q2
2020
Jun 30, 2019
$257.00M
Aug 6, 2020